Navigation Links
First Boston Pharma, LLC Acquires NutraMax Products, Inc.
Date:5/13/2009

GLOUCESTER, Mass., May 13 /PRNewswire/ -- First Boston Pharma announces the acquisition of NutraMax, Products, Inc., a contract manufacturer of solid dose and soft chew pharmaceuticals and supplements. The company will now be known as First Boston Pharma, LLC.

Leading the First Boston Pharma organization is Mario Medri, one of the industry's foremost innovators in over-the-counter ("OTC") drugs and supplement formulations. With over 40 years of experience in the consumer packaging goods industry, Medri has developed a multitude of products in the OTC drug and supplements categories, as well as flavors, fragrances, confections, foods and cosmetics. He holds over 15 product and process patents. Medri's many contributions to the market include inventing soft chews as a vehicle for delivery of OTC drugs and supplements and developing new products and technologies for pectin/menthol cough drops, honey liquid center cough drops and liquid center throat lozenges.

"The acquisition by Mario and the First Boston Pharma Group will propel the company further and faster along the trajectory we are on, particularly with designer products for pharmaceuticals and supplement markets," says Rodney Plunkett, Executive Vice President of First Boston Pharma. "To have the industry's foremost innovator leading First Boston Pharma into the future is an exciting prospect for us and for our customers," adds Plunkett.

The acquisition of NutraMax by First Boston Pharma will provide the necessary resources for the company to pursue its strategy of innovation in the over-the-counter drugs and supplements categories. The company will drive its growth strategy though investment in additional R&D, and in unique production capabilities. "One of our key strategies is to move to a supply base integrity model, which gives our customers the differentiated products they need, when they want them," says Medri.

About First Boston Pharma, LLC:

First Boston Pharma, LLC is a contract manufacturer of solid dose, soft chew, liquid, tablet and chewing gum based pharmaceuticals and supplements servicing branded companies and retailer private label products. The company provides turnkey services to customers wishing to introduce new products from product ideation to R&D, product development to production. Headquartered in Gloucester, MA, First Boston Pharma has an additional facility in Brockton, MA. All facilities are FDA registered drug manufacturing sites, and also cGMP and DSHEA compliant. For more information, visit www.Firstbostonpharma.com

LINKS

Mario Medri mmedri@1stbp.com

Rodney Plunkett rplunkett@1stbp.com

First Boston Pharma, LLC www.firstbostonpharma.com


'/>"/>
SOURCE First Boston Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Super Lice Repelled by All-Natural Products First Ever Independent Study Shows
2. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
3. China Medicine Announces First Quarter 2009 Results
4. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
5. Pharmos Corporation Reports 2009 First Quarter Results
6. Pregis Announces First Quarter 2009 Financial Results
7. Access to care leads Americans priorities in first-ever public study of health value
8. Access to Care Leads Americans Priorities in First-Ever Public Study of Health Value
9. The Nielsen Company Launches First-Ever CLIO Healthcare Awards Acknowledging Creative Excellence in Healthcare Communications
10. Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
11. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: